SLC5A2 and diabetes mellitus: While suggesting that metformin and sulphonylurea being generally safe, the Malaysian Clinical Practice Guideline (CPG) on the Management of Heart Failure (HF) also recommends SGLT-2 inhibitor in the treatment of diabetes in patients with HF (3).